Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Isotretinoin | Xeractan | Details | ||
| Methylphenidate | Ritalin | Details | ||
| Pomalidomide | Pomalidomide SPC | Details | ||
| Clopidogrel | Plavix | Details | ||
| Vemurafenib | Zelboraf | Details | ||
| Rivastigmine | Exelon | Details | ||
| Topiramate | Topamax | Details | ||
| Domperidone | Motilium | Details | ||
| Ofatumumab | Arzerra | Details | ||
| Belimumab | Benlysta | Details |
